295 related articles for article (PubMed ID: 20647647)
1. Comparison of immunological abnormalities of lymphocytes in bone marrow in myelodysplastic syndrome (MDS) and aplastic anemia (AA).
Li X; Xu F; He Q; Wu L; Zhang Z; Chang C
Intern Med; 2010; 49(14):1349-55. PubMed ID: 20647647
[TBL] [Abstract][Full Text] [Related]
2. [Abnormal polarization of T lymphocyte induces negative hematopoietic regulation in myelodysplastic syndromes].
Wu LY; Li X; Chang CK; Ying SX; Pu Q
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):549-54. PubMed ID: 18078133
[TBL] [Abstract][Full Text] [Related]
3. [Changes and clinical significance of CD8(+) T cell subset in patients with aplastic anemia, myelodysplastic syndrome and acute myeloid leukemia].
Zhang JY; Xu HZ; Yin DM; Feng XM; Sui XH; Cui B; Ma CY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Feb; 21(1):203-8. PubMed ID: 23484720
[TBL] [Abstract][Full Text] [Related]
4. Comparison of T lymphocyte subsets in aplastic anemia and hypoplastic myelodysplastic syndromes.
Zhang HF; Huang ZD; Wu XR; Li Q; Yu ZF
Life Sci; 2017 Nov; 189():71-75. PubMed ID: 28935248
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of Lymphocyte Subsets in Peripheral Blood of Patients with Aplastic Anemia or Hypoplastic Myelodysplastic Syndrome].
Lv YF; Yan ZY; Chen NY; Wu JH; Liu B; Wang GL; Wang J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1505-1510. PubMed ID: 27784383
[TBL] [Abstract][Full Text] [Related]
6. In vitro deprivation of CD8(+)CD57(+)T cells promotes the malignant growth of bone marrow colony cells in patients with lower-risk myelodysplastic syndrome.
Zheng Z; Qianqiao Z; Qi H; Feng X; Chunkang C; Xiao L
Exp Hematol; 2010 Aug; 38(8):677-84. PubMed ID: 20394797
[TBL] [Abstract][Full Text] [Related]
7. Selective reduction of natural killer T cells in the bone marrow of aplastic anaemia.
Zeng W; Maciejewski JP; Chen G; Risitano AM; Kirby M; Kajigaya S; Young NS
Br J Haematol; 2002 Dec; 119(3):803-9. PubMed ID: 12437663
[TBL] [Abstract][Full Text] [Related]
8. [Study of Th cell subsets in bone marrow of myelodysplastic syndromes patients].
Wang XL; Shao ZH; Yao C; He GS; Liu H; Shi J; Bai J; Cao YR; Tu MF; Wang HQ; Xing LM; Sun J; Jia HR; Yang CL
Zhonghua Xue Ye Xue Za Zhi; 2005 Dec; 26(12):743-5. PubMed ID: 16620580
[TBL] [Abstract][Full Text] [Related]
9. Analysis of bone marrow and peripheral blood immunoregulatory lymphocytes in patients with myelodysplastic syndrome.
Iwase O; Aizawa S; Kuriyama Y; Yaguchi M; Nakano M; Toyama K
Ann Hematol; 1995 Dec; 71(6):293-9. PubMed ID: 8534761
[TBL] [Abstract][Full Text] [Related]
10. Increased risk for aplastic anemia and myelodysplastic syndrome in individuals lacking glutathione S-transferase genes.
Sutton JF; Stacey M; Kearns WG; Rieg TS; Young NS; Liu JM
Pediatr Blood Cancer; 2004 Feb; 42(2):122-6. PubMed ID: 14752874
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of lymphocyte immune abnormality in 52 cases of children idiopathic aplastic anemia].
Chen C; Wei J; Li YF; Huang SL; Fang JP; Zhou DH; Xue HM; Huang K
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Oct; 16(5):1091-5. PubMed ID: 18928602
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow lymphocyte subsets in myelodysplastic syndromes.
Hilbe W; Eisterer W; Schmid C; Starz I; Silly H; Duba C; Ludescher C; Thaler J
J Clin Pathol; 1994 Jun; 47(6):505-7. PubMed ID: 8063930
[TBL] [Abstract][Full Text] [Related]
13. [Changes of HLA-DR15 and immunoglobulin, T lymphocyte subsets in patients with aplastic anemia, myelodysplastic syndrome and their significance].
Cui JX; Pei MF; Zhang GS; Xu M
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):111-5. PubMed ID: 20137129
[TBL] [Abstract][Full Text] [Related]
14. [Cytogenetic studies on 334 myelodysplastic syndrome (MDS), aplastic anemia (AA) and other hematological diseases].
Feng BZ; Lei JL; Han JZ
Zhonghua Nei Ke Za Zhi; 1994 Nov; 33(11):754-7. PubMed ID: 7600865
[TBL] [Abstract][Full Text] [Related]
15. Clinical impact of dysplastic changes in acquired aplastic anemia: A systematic study of bone marrow biopsies in children and adults.
Marchesi RF; Velloso EDRP; Garanito MP; Leal AM; Siqueira SAC; Azevedo Neto RS; Rocha V; Zerbini MCN
Ann Diagn Pathol; 2020 Apr; 45():151459. PubMed ID: 32000075
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotype of myeloid granulocytes: a pilot study for distinguishing myelodysplastic syndrome and aplastic anemia by flow cytometry.
Huang M; Li J; Zhao G; Sui X; Zhao X; Xu H
Int J Lab Hematol; 2010 Jun; 32(3):275-81. PubMed ID: 19968721
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplastic syndrome and aplastic anemia: distinct entities or diseases linked by a common pathophysiology?
Barrett J; Saunthararajah Y; Molldrem J
Semin Hematol; 2000 Jan; 37(1):15-29. PubMed ID: 10676908
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow and peripheral blood lymphocyte phenotype in patients with bone marrow failure.
Maciejewski JP; Hibbs JR; Anderson S; Katevas P; Young NS
Exp Hematol; 1994 Oct; 22(11):1102-10. PubMed ID: 7925777
[TBL] [Abstract][Full Text] [Related]
19. [Study on the immunophenotype of myeloid cells in myelodysplastic syndromes and its clinical implications].
Shao Z; Chen G; Lin Z; Zhang Y; Hao Y; Chu Y; Qian L; Yang T; Yang C; Feng B
Zhonghua Xue Ye Xue Za Zhi; 1997 Feb; 18(2):80-3. PubMed ID: 15622783
[TBL] [Abstract][Full Text] [Related]
20. [Study of subpopulations of lymphocytes in the bone marrow of patients with myelodysplastic syndromes].
Wiater E; Dwilewicz-Trojaczek J
Pol Arch Med Wewn; 2006 Mar; 115(3):210-8. PubMed ID: 18468426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
